Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma
NCT04309409
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
374
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma Stage II
Interventions
DRUG:
Nivolumab
Sponsor
University Hospital, Essen